ClinicalTrials.govpublic full text
Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults
hepatitis b, adjuvanted hepatitis b vaccine, hepatitis b, engerix™-b, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807507
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.